Please login to the form below

Not currently logged in


This page shows the latest Opzelura news and features for those working in and with pharma, biotech and healthcare.

FDA approves Incyte’s Opzelura for vitiligo

FDA approves Incyte’s Opzelura for vitiligo

With this latest approval, Opzelura is the first and only FDA-approved treatment for repigmentation in patients with vitiligo. ... Opzelura has been approved for continuous topical use twice daily to affected areas of up to 10% body surface area for

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Subscribe to our email news alerts

Featured jobs


Add my company

OncoSec is a clinical-stage biotechnology company focused on developing cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target...

Latest intelligence

Environment: where does the pharmaceutical industry stand?
The communication challenge of helping he next generation to be healthier
As the pressure on the health service increases the health of the next generation is vital for everyone. How do we show positive attitudes and change behaviour while future proofing...
Are we losing sight of what the democratisation of healthcare really looks like?
We have a core responsibility as healthcare communicators to consistently drive for better inclusion, engagement and compliance. What does the ‘democratisation of healthcare’ really look like?...